Clover Corporation Limited

CLV

AU000000CLV2

Clover Corporation Limited is an Australia-based company, which is focused on technology, new product development and commercialization. The Company's microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company's product offerings include docosahexaenoic acid (DHA) Oils and DHA Powders. Its DHA Oils include Nu-Mega HiDHA tuna oils and Ocean Gold. Its products are sourced from tuna oil. Its DHA Powders include Nu-Mega Driphorm powders and Nu-Mega Driphorm HA. Nu-MegaDriphorm powders utilize MicroMax technology to microencapsulate nutritional oils. Nu-Mega Driphorm powders are used in a range of infant formulas, follow-on formulas, growing up milks and food applications. Its Nu-Mega Driphorm HA is used for non-dairy applications.

Sector

Food Processing

Calendar

2024-09-18 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Clover Corporation Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.52 AUD

Average target price

0.6 AUD

Spread / Average Target

+15.38%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
CLOVER CORPORATION LIMITED	-36.97%	56.63M
ZHEJIANG NHU COMPANY LTD.	+8.20%	7.78B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.20%	6.52B
BYHEALTH CO., LTD	-8.10%	3.67B
THE SIMPLY GOOD FOODS COMPANY	-13.13%	3.44B
XIAMEN KINGDOMWAY GROUP COMPANY	-14.57%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-42.27%	879M
USANA HEALTH SCIENCES, INC.	-18.90%	836M
JAMIESON WELLNESS INC.	-16.45%	802M

Special Foods & Wellbeing Products

Market Closed - Australian S.E. Other stock markets 02:10:44 2024-04-26 am EDT			5-day change	1st Jan Change
0.52 ^AUD	-0.95%		-0.95%	-36.97%

Mar. 20	Clover Swings to Loss in H1 FY24; Shares Down 16%	MT
Mar. 19	Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2024	CI

Clover Swings to Loss in H1 FY24; Shares Down 16%	Mar. 19	MT
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2024	Mar. 19	CI
Clover Corporation Limited(ASX:CLV) dropped from S&P/ASX All Ordinaries Index	Mar. 17	CI
Transcript : Clover Corporation Limited - Shareholder/Analyst Call	Nov. 22
Clover Corporation Limited Declares Payment of Final Dividend for the Financial Year 2023	Nov. 20	CI
Clover Corporation Limited Declares Fully Franked Final Dividend for the Financial Year Ended 31 July 2023, Payable on 20 November 2023	23-09-25	CI
Clover Corporation Limited Reports Earnings Results for the Full Year Ended July 31, 2023	23-09-25	CI
Clover Corporation Limited(ASX:CLV) dropped from S&P/ASX Emerging Companies Index	23-03-20	CI
Clover Corporation Limited Declares Fully Franked Final Dividend for First Half of Financial Year 2023, Payable on 27 April 2023	23-03-14	CI
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2023	23-03-14	CI
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2023	23-03-14	CI
Clover Corporation Seeks Mergers and Acquisitions	22-11-23	CI
Transcript : Clover Corporation Limited - Shareholder/Analyst Call	22-11-23
Clover Declares FY22 Final Dividend	22-11-21	MT
Clover Corporation Limited Payment of Final Dividend for the Financial Year 2022	22-11-21	CI
Clover Informs Study Results by the South Australian Health and Medical Research Institute	22-10-26	CI
Clover Corporation Limited Declares Fully Franked Final Dividend for the Year Ended 31 July 2022, Payable on 22 November 2022	22-10-18	CI
Clover Corporation Limited(ASX:CLV) dropped from S&P Global BMI Index	22-09-19	CI
UBS Upgrades Clover to Buy From Neutral, Adjusts Price Target to AU$1.35 From AU$1.40	22-09-16	MT
Clover's Net Profit After Tax Jumps 18.8% in FY22	22-09-14	MT
Clover Corporation Limited Reports Earnings Results for the Full Year Ended July 31, 2022	22-09-13	CI
Clover Improves Cognitive Development of Prematurely Born Children	22-03-21	MT
Clover Corporation Limited Announces the Release of New Results from the Clinical Research Study Called the N3RO Trial	22-03-20	CI
UBS Downgrades Clover to Neutral From Buy, Adjusts Price Target to AU$1.4 From AU$1.85	22-03-18	MT
Clover Records Lower Fiscal H1 Profit	22-03-16	MT

Clover Corporation Limited

Equities

CLV